ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The price of shares in Syngenta spiked 12% in the past week on the back of media reports that the Swiss agricultural chemicals giant could be a $40 billion takeover target for Monsanto. Both firms declined to comment on a possible deal. Analysts at equity research firm Jefferies suggested in a research note that Monsanto’s acquisition of Syngenta would provide the St. Louis firm with diversification away from its glyphosate herbicide and create a market leader in seeds, crop protection chemicals, agchem distribution, and biological products. However, partnerships or asset swaps between the two firms would be more likely than an acquisition, Jefferies states.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X